← Open Payments lookup

BENJAMIN LEVRON: Open Payments

NPI 1184159501 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,059 in 47 payments from 14 companies in 2025. Trend: 2023 $1,273 · 2024 $1,427 · 2025 $1,059

Food & beverage: $1,060
CompanyPaymentsAmount
Gilead Sciences, Inc.11$293
Lilly USA, LLC7$220
ABBVIE INC.9$141
Axsome Therapeutics, Inc.3$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
AstraZeneca Pharmaceuticals LP3$58
Kowa Pharmaceuticals America, Inc.2$40
Novo Nordisk Inc2$38
Amgen Inc.2$34
Abbott Laboratories1$31

Products named: Yeztugo, ZEPBOUND, UBRELVY, MOUNJARO, Auvelity, CAPLYTA, VRAYLAR, FARXIGA.

Industry payments across LA — which companies pay providers there.